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Background
Chronic kidney disease (CKD) is a comorbid condition 
with high economic burden. Patients need multiple 
medications and pharmacists provide care that improves 
outcomes. Al Raiisi et al recently completed a systematic 
review showing a paucity of information on the structures 
and processes of clinical pharmacy services (CPS) and a 
need to define core outcomes. More work is needed to 
describe renal CPS which reflects developments such as 
non-medical prescribing (NMP).
Purpose
To describe behaviours and experiences of clinical 
pharmacists on provision of care to patients with CKD.
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Results
Results 
Although the literature suggest that there is still lack of 
good quality evidence of pharmacists role in caring for renal 
patients and the outcomes are diverse. Yet it is apparent 
with the best available evidence that pharmacists caring for 
renal patients may have positive impact on the outcomes of 
these patients. Emerging results of the survey indicate high 
levels of clinical practice including prescribing. 
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A THEORETICALLY BASED CROSS-SECTIONAL SURVEY ON THE 
BEHAVIOURS AND EXPERIENCES OF CLINICAL PHARMACISTS 
CARING FOR CHRONIC KIDNEY DISEASE PATIENTS.
Development of the survey tool 
•An online survey tool was developed based on the 
Theoretical Domains Framework (TDF) to generate 
items relating to influences on behaviours and the 
CFIR to develop questions on the implementation of 
the service.
•The development of the survey tool followed a 
rigorous iterative process. 
Setting and participants
•The participants were the members of UK renal 
pharmacy group who are currently practising clinical 
pharmacy in the care of patients with CKD in the UK.
• 71 responses (50% response rate), (n = 64) currently 
practising clinical pharmacy in the care of patients 
with CKD in the UK.
Table 1: Demographic characteristics (N=64)
Service Inpatient n (%) Outpatient n (%)
General Pharmaceutical Care 56 (87.5) 40 (62.5)
Dialysis 54 (84.4) 38 (59.4)
Transplant 46 (71.9) 37 (57.8)
Polypharmacy review 50 (78.1) 28 (43.8)
Targeted CKD medication review 50 (78.1) 27 (42.2)
Table 2: Characteristics of clinical pharmacy services you provide for with CKD (N=64)
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Figure 1: Status of prescribing for patients with CKD (N=64)
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Figure 2: Area(s) of clinical practice relating to the care of patients with CKD do 
pharmacists prescribe in (N=48)
Title Categories n (%)
Gender Male 14 (21.9)
Female 50 (78.1)
Age Less than 30 years 14 (21.9)
31 - 40 years 33 (51.6)
41 - 50 years 10 (15.6)
51 - 60 years 7 (10.9)
61 year and above 0 (0)
Geographical area of practice England 48 (75)
Scotland 10 (15.6)
Wales 4 (6.3)
Northern Ireland 2 (3.1)
Academic qualifications (Multiple 
selection allowed)
BSc 16 (10.2)
MPharm 46 (29.3)
Postgraduate diploma 49 (31.2)
Postgraduate certificate 11 (7)
MSc 16 (10.2)
PhD 3 (1.9)
Other 16 (10.2)
Years qualified as a pharmacist less than a year 0 (0)
1-5 years 9 (14.1)
6-10 years 13 (20.3)
11-15 years 17 (26.5)
16 - 20 years 10 (15.6)
More than 20 years 14 (21.9)
Missing 1 (1.6)
Table 3: Development and implementation of your CLINICAL PHARMACY practice based on 
CFIR constructs (N=64)
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